Advertisement

Topics

REGISTRATION CLOSING FOR THE 4TH ANNUAL CLINICAL DEVELOPMENT AND TRIALS ASIA CONGRESS & 5TH ANNUAL PHARMA R&D WORLD ASIA CONGRESS

11:10 EST 7 Jan 2015 | BioPortfolio

With only three weeks to go until the 4th Annual Clinical Development and Trials Asia Congress, and co-located 5th Annual Pharma R&D World Asia Congress, registration to attend will be closing on the 16th January 2015.

Taking place on the 27th & 28th January 2015 in Shanghai, the event will be attended by industry leaders in Clinical Development & Clinical Trials Development in Asia, and will offer invaluable insights on successful strategies and technologies in enabling clinical development, clinical outsourcing strategies and clinical trial management. Congress streams include:

  • Clinical Development Activities & Clinical Outsourcing Strategies
  • Featured Technology Stream: Enabling Technologies for Drug Development and Personalised Medicine
  • Clinical Trials Management Strategies in Asia and Asia Pacific Regions
  • Innovation Strategies to Advance R&D in Asia

As well as these streams, three VP and Director Panel Discussions will also take place on the following topics: Will Asia “Produce” in Regards to Drug Development?; Regulatory updates for Registration for Multinational Clinical Trials – China, Japan, South Korea & Singapore; and Innovation Strategies to Advance R&D in Asia & R&D Collaborations.

To ensure that delegates are exposed to the highest level of expertise, our speaker programmes are carefully researched. Confirmed speakers so far include:

  • Hua Mu Senior Vice President, Global Head of Product Development Service and Partnership Business Unit, WuXi AppTec (Shanghai) Co., Ltd
  • Dan Paulson Vice President, Global Clinical Development, Group Head, Cardiovascular Risk Management and Women’s HealthCare, Bayer HealthCare Company Limited Global R&D Centre
  • Akhilesh Sharma Vice President & Global Head Global Medical Affairs, Dr. Reddy's Laboratories India
  • Cezary Statuch, Vice President of R&D, Bristol-Myers Squibb, China
  • Ralf Altmeyer, Director General, Institut Pasteur Shanghai, Chinese Academy of Sciences

To find out who else will be speaking at this two-day event, and to see the Congress agenda in full, please visit (http://www.clinicalasia-congress.com/download-agenda-marketing/).

With only ten spaces remaining, Oxford Global Conferences are delighted to be able to offer the heavily discounted registration deal of two passes for the price of S$600. With registration closing on the 16th January 2015, and only a limited number of these passes now remaining, please contact Steph Punfield on s.punfield@oxfordglobal.co.uk or call +44 (0)1865 248455 to book your place today.

NEXT ARTICLE

More From BioPortfolio on "REGISTRATION CLOSING FOR THE 4TH ANNUAL CLINICAL DEVELOPMENT AND TRIALS ASIA CONGRESS & 5TH ANNUAL PHARMA R&D WORLD ASIA CONGRESS"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...